
| 7:00 am | 7:30 am | Registration/Breakfast with Exhibitors |
| 7:30 am | 7:45 am | Welcome & Introduction Charles L. Brown, III, MD and C. Michael Valentine, MD |
| White Varietals: Lighter Content, Crispy Start |
| 7:45 am | 8:15 am | CAC and Next Generation CTA: The New Era of Discovery Szilard Voros, MD |
| 8:15 am | 8:30 am | Discussion |
| 8:30 am | 9:00 am | Direct Thrombin Inhibitors Anti-Platelet Therapy: Current Practice and Future Directions E. Magnus Ohman, MD |
| 9:00 am | 9:15 am | Discussion |
| 9:15 am | 9:45 am | DES vs BMS--What Does the Data Tell Us About Long Term Safety and Outcomes? Ralph G. Brindis, MD |
| 9:45 am | 10:00 am | Discussion |
| 10:00 am | 10:15 am | Break |
| 10:15 am | 10:45 am | Arterial Puncture Management: Current State-of-the-Art and Future Options Charles L. Brown, III, MD |
| 10:45 am | 11:00 am | Discussion |
| 11:00 am | 11:30 am | Pertinent Case Review and Discussion Charles L. Brown, III, MD and C. Michael Valentine, MD |
| 11:30 am | Lunch |
| 6:00pm | Napa Valley Reserve Tasting |
| 7:00 am | 7:30 am | Continental Breakfast |
| Red Varietals: Heavier Content, with More of a Bite |
| 7:30 am | 8:00 am | LMD and Multivessel CAD: To Stent or Not to Stent? Richard A. Schatz, MD |
| 8:00 am | 8:15 am | Discussion |
| 8:15 am | 8:45 am | New Approaches to CTO: Have We Learned Anything from the East? Robert S. Schwartz, MD |
| 8:45 am | 9:00 am | Discussion |
| 9:00 am | 9:30 am | Percutaneous and Hybrid Valve Management: State-of-the-Art and Future Options Peter J. Fitzgerald, MD, PhD |
| 9:30 am | 9:45 am | Discussion |
| 9:45 am | 10:00 am | Break |
| 10:00 am | 10:30 am | LV Recovery Management: The Interventionalist's Role Steven J. Yakubov, MD |
| 10:30 am | 10:45 am | Discussion |
| The Meritage |
| 10:45 am | 11:45 am | Blending of Interventional Medicine and Business: Survival Hints for The New Era of Healthcare Delivery Charles L. Brown, III, MD and C. Michael Valentine, MD |
| 11:45 am | 12:00 pm | Discussion |
